Exercise testing and prognosis in adult cystic fibrosis

Thorax

Volumn 52, Issue 3, 1997, Pages 291-293

  Moorcroft, A J ^a   Dodd, M E ^a   Webb, A K ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

cystic fibrosis; exercise capacity; prognosis

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; EXERCISE TEST; FORCED EXPIRATORY VOLUME; HUMAN; LIFE EXPECTANCY; LUNG FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0030936491     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.3.291     Document Type: Article

References (15)

1. Fitzsimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
2. Penketh ARL, Wise A, Mearns MB, Hodson ME, Batten JC. Cystic fibrosis in adolescents and adults. Thorax 1987; 42:526-32.
3. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-91.
4. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187-91.
5. Huang NN, Schidlow DV, Szatrowski TH, Palmer J, Laraya-Cuasay LR, Yeung W, et al. Clinical features, survival rate and prognostic factors in young adults with cystic fibrosis. Am J Med 1987;85:871-7.
6. Sharpies L, Hathaway T, Dennis C, Caine N, Higenbottam T, Wallwork J. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant 1993;12:669-74.
7. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Mcd 1992;327:1785-8.
8. Lewin LO, Byard PJ, Davies BD. Effect of Pseudomonas cepada colonisation on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 1990;43;125-31.
9. Zinman R, Corey M, Coates AL, Canny GJ, Connolly J, Levison H, et al. Nocturnal home oxygen in the treatment of hypoxaemic cystic fibrosis patients. J Pediatr 1989;114: 368-77.
10. Knudson RJ, Lebowitz MD, Hollberg CJ, Burrows B. Changes in the normal maximum expiratory Mow-volume curve with growth and ageing. Am Rev Respir Dis 1983; 127:725-34.
11. Jones NL. Clinical exercise testing. 3rd edn. Philadelphia: WB Saunders, 1988.
12. Godfrey S, Mearns M. Pulmonary function and response to exercise in cystic fibrosis. Arch Dis Child 1971;46: 144-51.
13. Marcotte JE, Grisdale BA, Levison H, Coates AL, Canny GJ. Multiple factors limit exercise capacity in cystic fibrosis. Pediatr Pulmonol 1986;2:274-81.
14. British Paediatric Working Party on CF. Cystic fibrosis in the United Kingdom 1977-85: an improving picture. BMJ 1988;297:1599-602.
15. Webb AK, Dodd ME, Moorcroft J. Exercise and cystic fibrosis. J R Soc Med 1995;88:30-6.